Lista de obras -

2023 ESC Guidelines for the management of acute coronary syndromes

artículo científico publicado en 2023

2023 ESC Guidelines for the management of acute coronary syndromes

artículo científico publicado en 2023

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

artículo científico publicado en 2021

Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation

artículo científico publicado en 2019

Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires?

scientific article published on 13 September 2018

Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

artículo científico publicado en 2021

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

artículo científico publicado en 2017

Coronary spasm: an unusual cause of ST elevation ⬇️

artículo científico publicado el 12 de noviembre de 2010

Coronary thrombosis: In vivo, ex vivo and in vitro ⬇️

artículo científico publicado el 14 de abril de 2009

Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis

artículo científico publicado en 2018

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

artículo científico publicado en 2019

Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC-PPCI randomised controlled trial

artículo científico publicado en 2020

Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment

scientific article published on 09 December 2020

Fatal heart block from intentional yew tree (Taxus baccata) ingestion: a case report

artículo científico publicado en 2019

Identifying the aetiology of left ventricular hypertrophy in an athlete: importance of lifestyle modification ⬇️

artículo científico publicado el 1 de enero de 2009

Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis

scientific article published on 28 January 2020

Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture

scientific article published on 01 April 2019

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease ⬇️

artículo científico publicado el 9 de octubre de 2012

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study

artículo científico publicado en 2022

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

artículo científico publicado en 2022

Low-grade endotoxaemia and platelets: a deadly aggregation

scientific article published on 20 January 2020

METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial

scientific article published on 19 November 2018

Metabolism of ticagrelor in patients with acute coronary syndromes

artículo científico publicado en 2018

Novel oral anticoagulants in acute coronary syndrome ⬇️

artículo científico publicado el 16 de septiembre de 2012

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes

scientific article published on 14 November 2019

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement

artículo científico publicado en 2020

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

artículo científico publicado en 2020

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with

scientific article published on 01 February 2020

Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19

artículo científico publicado en 2020

Temporary transvenous pacing: endangered skill ⬇️

artículo científico publicado el 6 de septiembre de 2011

Lista de obras de

2023 ESC Guidelines for the management of acute coronary syndromes

2023 ESC Guidelines for the management of acute coronary syndromes

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study

Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation

Assessment of adherence to medication in patients after myocardial infarction treated with percutaneous coronary intervention. Is there a place for newself-reported questionnaires?

Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

Coronary spasm: an unusual cause of ST elevation ⬇️

Coronary thrombosis: In vivo, ex vivo and in vitro ⬇️

Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC-PPCI randomised controlled trial

Endogenous fibrinolysis - relevance to clinical thrombosis risk assessment

Fatal heart block from intentional yew tree (Taxus baccata) ingestion: a case report

Identifying the aetiology of left ventricular hypertrophy in an athlete: importance of lifestyle modification ⬇️

Impact of Preadmission Morphine on Reinfarction in Patients With ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention: A Meta-Analysis

Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease ⬇️

Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study

Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

Low-grade endotoxaemia and platelets: a deadly aggregation

METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial

Metabolism of ticagrelor in patients with acute coronary syndromes

Novel oral anticoagulants in acute coronary syndrome ⬇️

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Prolonged antithrombotic therapy in patients after acute coronary syndrome: A critical appraisal of current European Society of Cardiology guidelines

Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with

Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19

Temporary transvenous pacing: endangered skill ⬇️